![](https://startllc.com/wp-content/uploads/2023/11/Abbott-Aveir-dual-chamber-leadless-pacemaker-300x195-1.webp)
Abbott launches dual-chamber pacemaker with first U.S. implants
The first U.S. commercial cases have been completed with the Abbott (NYSE: ABT)+
Aveir dual-chamber leadless pacemaker technology.
The first U.S. commercial cases have been completed with the Abbott (NYSE: ABT)+
Aveir dual-chamber leadless pacemaker technology.
An advanced closed-loop anesthesia delivery system that monitors brain state to tailor propofol dose and achieve exactly the desired level of unconsciousness could reduce post-op side effects.